CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 68911-69051 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T98157","span":{"begin":0,"end":140},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We now report additional data from this trial on the possible role of daclizumab as an anti-inflammatory agent that affects asthma outcomes."}

{"project":"Epistemic_Statements","denotations":[{"id":"T120","span":{"begin":0,"end":140},"obj":"Epistemic_statement"}],"text":"We now report additional data from this trial on the possible role of daclizumab as an anti-inflammatory agent that affects asthma outcomes."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T168","span":{"begin":0,"end":140},"obj":"Sentence"}],"text":"We now report additional data from this trial on the possible role of daclizumab as an anti-inflammatory agent that affects asthma outcomes."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T541","span":{"begin":124,"end":130},"obj":"Disease"}],"attributes":[{"id":"A541","pred":"mondo_id","subj":"T541","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"}],"text":"We now report additional data from this trial on the possible role of daclizumab as an anti-inflammatory agent that affects asthma outcomes."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T285","span":{"begin":124,"end":130},"obj":"Phenotype"}],"attributes":[{"id":"A285","pred":"hp_id","subj":"T285","obj":"http://purl.obolibrary.org/obo/HP_0002099"}],"text":"We now report additional data from this trial on the possible role of daclizumab as an anti-inflammatory agent that affects asthma outcomes."}